TRVI Trevi Therapeutics, Inc.
$15.90▼ -0.06%
Healthcare
Other
After hours
$15.90▲ +0.00%
Sep 11, 7:30 PM ET
Volume 2.02M
Avg Volume (10D) 1.34M
Key Metrics & Fundamentals
Market Cap
$2.27B
P/E Ratio
–
Div Yield
–%
52W Range
7.65 - 20.22
% vs 50 MA
-10.74%
% vs 200 MA
12.48%
RSI-14
33.2
MACD Histogram
-0.1800
Beta (1Y vs SPY)
1.11
Free Cash Flow
-$17.55M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$20.48M
COGS
–
Operating Exp
$20.51M
Operating Income
-$20.51M
EBIT
-$20.51M
Pretax Income
-$17.82M
Net Income
-$17.80M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
Simply Wall St. · Sep 5, 2026 5:05 PM
Trevi Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire · Sep 3, 2026 11:30 AM
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
GlobeNewswire · Aug 26, 2026 11:30 AM
Trevi Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 6:04 PM
Oppenheimer Adjusts Trevi Therapeutics PT to $25 From $24, Maintains Outperform Rating
MT Newswires · Aug 7, 2026 1:41 PM
Trevi Therapeutics Inc (TRVI) (Q2 2026) Earnings Call Highlights: Advancing Phase 3 Pipeline ...
GuruFocus.com · Aug 7, 2026 5:08 AM
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 6, 2026 8:05 PM
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
GlobeNewswire · Jul 30, 2026 8:05 PM
Trevi Therapeutics to Participate in Upcoming August Conferences
GlobeNewswire · Jul 28, 2026 11:30 AM
BMO Capital Initiates Trevi Therapeutics at Outperform With $36 Price Target
MT Newswires · Jul 21, 2026 11:26 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TRVI's money flow as a full page
Social Sentiment
No Reddit posts found for TRVI.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.